Sirio Pharma earns healthy turnover on the international supplement market

17 May 2024 — Global nutraceutical specialist Sirio Pharma reports a 43% increase in turnover due to international sales, bringing the company’s revenue to US$508 million. Sirio’s core dosages are responsible for the record turnover, with softgel sales amounting to about 43% year-on-year, representing an annual growth of 54%.